Sysnav healthcare
Unlocking the potential of digital sensors in medecine

SYSNAV Healthcare is the first global player to develop a digital endpoint qualified by the European Medicines Agency (EMA) as representative of the patient’s motor functions and suitable for use in clinical studies. SYSNAV Healthcare aims to unlock the potential of real-world data in the medical field by adapting extremely precise motion-capture solutions based on magneto-inertial technology to the needs of health care professionals and patients.

Trustworthiness

The Syde platform is able to provide patient motion measurements captured in real-life environments that can help understand neurological and neuromuscular patterns.

Clinical Meaningfulness

SYSNAV Healthcare designs and qualifies reliable digital clinical outcomes meaningful for patients and regulators.

Patient-First

Collecing data in the most respectful and seamless way is paramount. We partner with patient associations to improve compliance through product improvement, design and services.

Starting point
Starting point2010
Several studies using commercial wearables fail to prove molecule efficacy. It is the starting point for Sysnav to consider the need of high precision tools in clinical fields
Proof of technology
Proof of technology2011
Sysnav Healthcare developed its motion reconstruction device, packaged in an at-home capable device
First approval
First approval2012
ActiMyo is approved by NHS
SV95 qualification as secondary endpoint
SV95 qualification as secondary endpoint2019
The clinical outcome assessment SV95C obtains the EMA qualification as a secondary endpoints for DMD.
Syde launch
Syde launch2020
A new device is designed based on patient"s and caregivers' advice: size, weight got miniaturized, autonomy and usability have been improved
Roche Partnership
Roche Partnership2022
Sysnav Healthcare and Roche enter a partnership to expand success beyond Duchenne Muscular Dystrophy (DMD).
SV95C qualification as a primary endpoint
SV95C qualification as a primary endpoint2023
SV95C is the first regulatory-qualified real-world digital outcome measure for use as a primary endpoint in pivotal studies of Duchenne Muscular Dystrophy.

They trust us!

SYSNAV Healthcare was created by the meeting of neuromuscular physicians and experts in search of innovative tools to improve and accelerate researchers and French experts in motion capture, driven by the major scientific challenge to adapt the innovative and ground-breaking magneto inertial technology to useful fields. Since the very start of the company, SYSNAV has focused on :

Scientific excellence

Teamwork

Innovation

And the desire to find solutions to complex equations and to advance on unresolved projects where others have not succeeded yet. Scientific curiosity and the taste for strategic challenges guide our missions.

Sysnav Healthcare is always looking for new talents.

News

Rejoignez l’étude Syde-CAR

Vous avez entre 18 et 65 ans.
Vous êtes en bonne santé.
Vous avez envie de faire progresser la recherche.